Vitamins-based therapeutics targeting chemotherapeutic resistance in mammary cancers: δ-tocotrienol (a derivative of Vitamin-E) inhibits mammary cancer recurrence through suppression of the SPSB1–c-MET pathway, 12/July/2014, 5.08 am

Vitamins-based therapeutics targeting chemotherapeutic resistance in mammary cancers: δ-tocotrienol (a derivative of Vitamin-E) inhibits mammary cancer recurrence through suppression of the SPSB1–c-MET pathway, 12/July/2014, 5.08 am

Vitamins-based therapeutics targeting chemotherapeutic resistance in mammary cancers: δ-tocotrienol (a derivative of Vitamin-E) inhibits mammary cancer recurrence through suppression of the SPSB1–c-MET pathway, 12/July/2014, 5.08 am 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated by: Dr L Boominathan PhD

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

Citation: Boominathan, Vitamins-based therapeutics targeting chemotherapeutic resistance in mammary cancers: δ-tocotrienol (a derivative of Vitamin-E) inhibits mammary cancer recurrence through suppression of the SPSB1–c-MET pathway, 12/July/2014, 5.08 am, Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Share
Start Typing